Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation and transcatheter arterial embolization both resulted in reduced pain for patients with ...
Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain (CLBP).
BRISBANE, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...
BRISBANE, Calif. - Pacira BioSciences, Inc. (NASDAQ:PCRX) announced results from a randomized 30-patient pilot study showing its iovera° cryoneurolysis treatment demonstrated better outcomes than ...
On Tuesday, Pacira BioSciences, Inc. (NASDAQ:PCRX) received FDA clearance to market a new Smart Tip designed to access the medial branch nerves to manage chronic low back pain. The ioveraº system is a ...
I’M CAROL CLARKE IN NEWS FOR YOUR HEALTH. FOR MILLIONS OF AMERICANS. THEY KNOW WHAT LOWER BACK PAIN FEELS LIKE. MANY OF THEM HAVE A TYPE CALLED VERTEBRAL PAIN. IT COMES FROM DAMAGE TO THE SPINE. OVER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback